The relationship between sequencing companies is frosty and beset by legal issues, which I’ve covered before here and here.  Keith Robison tends to cover in more detail 😉

Most recently, PacBio moved against Oxford Nanopore, we think claiming that ONT’s 2D technology violated their patent on CCR (link).

Well now the absolute latest is a filing by the University of California against Roger Chen and therefore Genia. If you click through to the documents (requires registration) you’ll see that UC claim Chen, with others, produced key inventions whilst at UC that he later assigned to Genia, but which should have automatically been assigned to UC according to UC’s “oath of allegiance”, which Chen signed as a UC employee.

It awaits to be seen how important this is and no doubt Chen/Genia/Roche will fight tooth and nail; however if the courts decide in UC’s favour it could spell the end of Genia, and at the very least see a large cash settlement with UC.

Fascinating times!